Video Experimental Relacionado
Updated: Sep 9, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
880
Impacto de la variabilidad de la bronquitis en los resultados de la EPOC
Joon Young Choi1, Yun Seok Kim1, Youlim Kim2
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
BMJ open respiratory research
|September 3, 2025
Resumen
Los pacientes con bronquitis crónica (CB) y bronquitis intermitente (IB) se enfrentan a mayores riesgos de exacerbación en comparación con aquellos con estado no bronquitis persistente (NB) en la enfermedad pulmonar obstructiva crónica (EPOC). Las tasas de disminución de la función pulmonar no diferían significativamente entre estos grupos.
Área de la Ciencia:
- Pulmonología
- Medicina de las vías respiratorias
- Epidemiología clínica
Sus antecedentes:
- La enfermedad pulmonar obstructiva crónica (EPOC) es un gran problema de salud mundial.
- El estado bronquitario es un fenotipo clave en la EPOC, que influye en los resultados clínicos.
- Comprender el impacto longitudinal del estado de bronquitis en serie es crucial para el manejo del paciente.
Objetivo del estudio:
- Evaluar el impacto de la bronquitis persistente, intermitente y crónica durante dos años en la frecuencia de exacerbación de la EPOC y el deterioro de la función pulmonar.
- Para identificar trayectorias clínicas distintas basadas en el estado de bronquitis en serie.
Principales métodos:
- Análisis de los datos de 1265 participantes en el Estudio de subgrupos de EPOC de Corea, una cohorte de observación prospectiva a nivel nacional.
- Clasificación de los pacientes en grupos de bronquitis no persistente (NB), bronquitis intermitente (IB) y bronquitis crónica (CB) basada en los subcuestionarios de la prueba de evaluación de la EPOC durante dos años.
- Evaluación de las tasas de exacerbación anualizadas y de la disminución longitudinal de la función pulmonar (VEF1, CVF).
Principales resultados:
- El estudio incluyó a 873 participantes NB, 272 IB y 120 CB.
- Los grupos de bronquitis crónica (CB) y bronquitis intermitente (IB) mostraron tasas más altas de exacerbaciones de moderadas a severas en comparación con el grupo de bronquitis persistente (NB).
- No se observaron diferencias significativas en las tasas anualizadas de disminución de la función pulmonar (FEV1, FVC) entre los tres grupos.
- Los fumadores actuales eran más frecuentes en los grupos CB e IB.
Conclusiones:
- Los pacientes con los fenotipos de bronquitis crónica (CB) y bronquitis intermitente (IB) tienen un riesgo significativamente mayor de exacerbaciones.
- El estado de bronquitis en serie no parece influir en la tasa de deterioro de la función pulmonar en pacientes con EPOC.
- Estos hallazgos ponen de relieve la importancia de controlar las exacerbaciones en pacientes con fenotipos de bronquitis crónica e intermitente.
Palabras clave:
Tos/Mecanismos/FarmacologíaEvaluación del resultado del pacientePercepción del asma y la falta de aireEnfermedad pulmonar obstructiva crónicaPrueba de la función respiratoriaMás Videos Relacionados
Videos de Conceptos Relacionados
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:20COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K